ロード中...
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
Objective: Perampanel is an approved anti-seizure drug. A new formulation of perampanel fine granules (FG; 1% perampanel) has been developed for patients who are unable to take tablets. Bioequivalence between the 4-mg FG and tablet perampanel formulations, as well as their safety and tolerability, w...
保存先:
| 出版年: | Int J Clin Pharmacol Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dustri-Verlag Dr. Karl Feistle
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659282/ https://ncbi.nlm.nih.gov/pubmed/32870153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP203781 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|